Drug Profile
Research programme: D-amino acid oxidase inhibitors - Eisai
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator MGI Pharma
- Class Small molecules
- Mechanism of Action D amino acid oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in USA
- 19 Nov 2008 Preclinical trials in Schizophrenia in USA (unspecified route)